EUDA Health (NASDAQ:EUDA) Stock Lifted to Hold by Wall Street Zen

Wall Street Zen upgraded shares of EUDA Health (NASDAQ:EUDA) to a hold rating in a report released on Saturday morning,Wall Street Zen reports.

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of EUDA Health in a research note on Wednesday, August 5th. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $55.00.

EUDA Health Price Performance

Shares of EUDA stock opened at $15.40 on Friday. EUDA Health has a 12-month low of $5.26 and a 12-month high of $71.80. The business has a 50 day simple moving average of $15.45 and a 200 day simple moving average of $14.28. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.53 and a quick ratio of 2.53.

EUDA Health (NASDAQ:EUDA) last posted its earnings results on Tuesday, September 29th. The company reported ($0.17) EPS for the quarter, missing the consensus estimate of $0.40 by ($0.57). The company had revenue of $1.73 million during the quarter, compared to analysts’ expectations of $9.61 million.

EUDA Health Company Profile

EUDA Health Holdings Limited is a healthcare technology company focused on providing digital and technology-enabled healthcare services. Through its platform and affiliated healthcare operations, the company aims to connect patients with medical professionals and make healthcare services more accessible through digital channels.

Its activities include telehealth and online medical consultations, healthcare information and patient-management services, and related wellness and medical support offerings.